|
Phase I study of AIC100 in relapsed and/or refractory advanced thyroid cancer and anaplastic thyroid cancer. |
|
|
No Relationships to Disclose |
|
|
Employment - AffyImmune Therapeutics |
Leadership - AffyImmune Therapeutics |
Stock and Other Ownership Interests - AffyImmune Therapeutics |
Travel, Accommodations, Expenses - AffyImmune Therapeutics |
|
|
Consulting or Advisory Role - Avalon GloboCare Corp |
Research Funding - Avalon GloboCare Corp |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Mediflix |
|
|
Research Funding - Novartis Pharmaceuticals UK Ltd. |
|
|
Employment - AffyImmune Therapeutics |
Stock and Other Ownership Interests - AffyImmune Therapeutics |
|
|
Employment - AffyImmune Therapeutics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Cerus; Haemonetics; Octapharm |
|
|
Stock and Other Ownership Interests - AffyImmune Therapeutics |
Consulting or Advisory Role - AffyImmune Therapeutics |
Research Funding - AffyImmune Therapeutics |
Patents, Royalties, Other Intellectual Property - Patents related to CAR T design and T cell imaging |
Other Relationship - AffyImmune Therapeutics |
|
|
Stock and Other Ownership Interests - HemOgenyx |
Honoraria - ADC Therapeutics; Autolus; Intellia Therapeutics; Pfizer |
Consulting or Advisory Role - CTI; Gamida Cell; Glycostem; HemOgenyx |
Research Funding - Bristol Myers Squibb Foundation; Calibr; Miltenyi Biotec; Orca Bio; Precision BioSciences |